{
  "ID": 57836,
  "GUID": "A8C69604-D2FC-4F19-8966-80F55050F61E",
  "File": "Res 1588-2017",
  "Name": "Recognizing September as Prostate Cancer Awareness Month in NYC.",
  "Title": "Resolution recognizing September as Prostate Cancer Awareness Month in New York City.",
  "TypeID": 1,
  "TypeName": "Resolution",
  "StatusID": 5040,
  "StatusName": "Filed (End of Session)",
  "BodyID": 14,
  "BodyName": "Committee on Health",
  "IntroDate": "2017-07-20T00:00:00Z",
  "AgendaDate": "2017-07-20T00:00:00Z",
  "PassedDate": "2017-12-31T00:00:00Z",
  "EnactmentDate": "0001-01-01T00:00:00Z",
  "Version": "*",
  "Sponsors": [
    {
      "ID": 7630,
      "Slug": "rafael-l-espinal-jr",
      "FullName": "Rafael L. Espinal, Jr."
    },
    {
      "ID": 7510,
      "Slug": "eric-a-ulrich",
      "FullName": "Eric A. Ulrich"
    }
  ],
  "History": [
    {
      "ID": 321447,
      "Date": "2017-07-20T13:25:00Z",
      "ActionID": 27,
      "Action": "Introduced by Council",
      "Description": "This Resolution was Introduced by Council",
      "BodyID": 1,
      "BodyName": "City Council",
      "Version": "*",
      "MatterStatusID": 2,
      "LastModified": "2017-07-17T17:23:46.66Z"
    },
    {
      "ID": 321608,
      "Date": "2017-07-20T13:30:00Z",
      "ActionID": 43,
      "Action": "Referred to Comm by Council",
      "Description": "This Resolution was Referred to Comm by Council to the Committee on Health",
      "BodyID": 1,
      "BodyName": "City Council",
      "EventID": 15682,
      "AgendaSequence": 111,
      "MinutesSequence": 134,
      "AgendaNumber": "~SPONSOR",
      "Version": "*",
      "AgendaNote": "Health",
      "MatterStatusID": 3,
      "LastModified": "2017-07-20T23:59:50.617Z"
    },
    {
      "ID": 322383,
      "Date": "2017-09-26T10:00:00Z",
      "ActionID": 54,
      "Action": "Hearing Held by Committee",
      "Description": "This Resolution was Hearing Held by Committee",
      "BodyID": 14,
      "BodyName": "Committee on Health",
      "EventID": 15735,
      "AgendaSequence": 6,
      "MinutesSequence": 19,
      "Version": "*",
      "MatterStatusID": 3,
      "LastModified": "2017-09-26T14:26:32.84Z"
    },
    {
      "ID": 323755,
      "Date": "2017-09-26T10:00:00Z",
      "ActionID": 17,
      "Action": "Laid Over by Committee",
      "Description": "This Resolution was Laid Over by Committee",
      "BodyID": 14,
      "BodyName": "Committee on Health",
      "EventID": 15735,
      "MinutesSequence": 20,
      "Version": "*",
      "MatterStatusID": 25,
      "LastModified": "2017-10-10T14:35:41.587Z"
    },
    {
      "ID": 329740,
      "Date": "2017-12-31T22:40:00Z",
      "ActionID": 5046,
      "Action": "Filed (End of Session)",
      "Description": "This Resolution was Filed (End of Session)",
      "BodyID": 1,
      "BodyName": "City Council",
      "Version": "*",
      "MatterStatusID": 5040,
      "LastModified": "2017-12-27T03:40:24.38Z"
    }
  ],
  "Attachments": [
    {
      "ID": 161151,
      "LastModified": "2017-10-10T14:35:23.103Z",
      "Name": "Committee Report 9/26/17",
      "Link": "https://nyc.legistar1.com/nyc/attachments/8eb37591-9627-4244-b1de-d37874efd0aa.doc",
      "Sort": 1
    },
    {
      "ID": 161396,
      "LastModified": "2017-10-03T15:22:44.427Z",
      "Name": "Hearing Testimony 9/26/17",
      "Link": "https://nyc.legistar1.com/nyc/attachments/e10fa96f-b05f-4425-9a76-dec6d69c55c0.PDF",
      "Sort": 2
    },
    {
      "ID": 161662,
      "LastModified": "2017-10-10T14:35:26.853Z",
      "Name": "Hearing Transcript 9/26/17",
      "Link": "https://nyc.legistar1.com/nyc/attachments/24629297-4bc9-4e15-ac68-b7ad10d329a9.pdf",
      "Sort": 3
    }
  ],
  "Summary": "",
  "TextID": 59852,
  "Text": "By Council Members Espinal and Ulrich\n \n      Whereas, Prostate cancer is the most common non-skin cancer among American men; and\n      Whereas, The American Cancer Society estimates there will be 161,360 new cases of prostate cancer in the United States in 2017, including over 10,000 in New York; and\n      Whereas, Prostate cancer is the second most common cause of death from cancer among white, African American, American Indian/Alaska Native, and Hispanic men, and the fourth most common cause of death from cancer among Asian/Pacific Islander men; and\n      Whereas, The risk of prostate cancer is 74 percent higher in blacks than in whites; and\n      Whereas, Different people have different symptoms for prostate cancer and some men do not have symptoms at all; and\n      Whereas, Prostate cancer death rates have been decreasing 3 percent per year since 1999, however, there are significant disparities in treatment, with African American and Hispanic men less likely to receive treatment compared to White men; and\n      Whereas, While it is a common cancer, most men with prostate cancer are older than 65 years and do not die from the disease because it usually grows slowly; and\n      Whereas, There are two tests that are commonly used to screen for prostate cancer; and\n      Whereas, The digital rectal exam (DRE) includes a doctor or nurse inserting a gloved, lubricated finger into the rectum to estimate the size of the prostate and feel for lumps or other abnormalities; and\n      Whereas, A second screening measures the prostate specific antigen (PSA) level in blood, as levels of PSA in the blood can be higher in men who have prostate cancer; and\n      Whereas, Currently, only a biopsy can definitively diagnose prostate cancer (a minor surgery to get small samples of prostate cells or tissues); and\n      Whereas, Men who are African American, over the age of 65, or who have a family history of prostate cancer are at higher risk and should be aware of risk factors and symptoms; and\n      Whereas, Men should talk to their doctor about their risk factors and whether screening for prostate cancer is right for them; now, therefore, be it\n      Resolved, That the Council of the City of New York recognizes September as Prostate Cancer Awareness Month in New York City.\n      \nCP\nLS 10821\n5/22/17",
  "RTF": "{\\rtf1\\fbidis\\ansi\\ansicpg1252\\deff0\\deflang1033\\deflangfe1033{\\fonttbl{\\f0\\froman\\fprq2\\fcharset0 Times New Roman;}}\n{\\colortbl ;\\red255\\green255\\blue255;}\n\\viewkind4\\uc1\n\\v0\\par\nBy Council Members Espinal and Ulrich\\par\n \\par\n\\pard\\cbpat1\\ltrpar\\fi720\\sl480\\slmult1\\qj Whereas, Prostate cancer is the most common non-skin cancer among American men; and\\par\nWhereas, The American Cancer Society estimates there will be 161,360 new cases of prostate cancer in the United States in 2017, including over 10,000 in New York; and\\par\nWhereas, Prostate cancer is the second most common cause of death from cancer among white, African American, American Indian/Alaska Native, and Hispanic men, and the fourth most common cause of death from cancer among Asian/Pacific Islander men; and\\par\nWhereas, The risk of prostate cancer is 74 percent higher in blacks than in whites; and\\par\nWhereas, Different people have different symptoms for prostate cancer and some men do not have symptoms at all; and\\par\nWhereas, Prostate cancer death rates have been decreasing 3 percent per year since 1999, however, there are significant disparities in treatment, with African American and Hispanic men less likely to receive treatment compared to White men; and\\par\nWhereas, While it is a common cancer, most men with prostate cancer are older than 65 years and do not die from the disease because it usually grows slowly; and\\par\nWhereas, There are two tests that are commonly used to screen for prostate cancer; and\\par\nWhereas, The digital rectal exam (DRE) includes a doctor or nurse inserting a gloved, lubricated finger into the rectum to estimate the size of the prostate and feel for lumps or other abnormalities; and\\par\nWhereas, A second screening measures the prostate specific antigen (PSA) level in blood, as levels of PSA in the blood can be higher in men who have prostate cancer; and\\par\nWhereas, Currently, only a biopsy can definitively diagnose prostate cancer (a minor surgery to get small samples of prostate cells or tissues); and\\par\nWhereas, Men who are African American, over the age of 65, or who have a family history of prostate cancer are at higher risk and should be aware of risk factors and symptoms; and\\par\nWhereas, Men should talk to their doctor about their risk factors and whether screening for prostate cancer is right for them; now, therefore, be it\\par\nResolved, That the Council of the City of New York recognizes September as Prostate Cancer Awareness Month in New York City.\\par\n\\par\n\\pard\\cbpat1\\ltrpar CP\\par\nLS 10821\\par\n5/22/17\\par\n}\n",
  "LastModified": "2017-12-27T03:40:24.503Z"
}
